Investigating the Effects and Mechanism of Rhodiola Rosea Injection on Cardiac Function in Rats with Chronic Heart Failure-Reference-Cited by-同舟云学术

Investigating the Effects and Mechanism of Rhodiola Rosea Injection on Cardiac Function in Rats with Chronic Heart Failure

Published:2023-10 Issue:12 Volume:26 Page:2238-2246
ISSN:1386-2073
Container-title:Combinatorial Chemistry & High Throughput Screening
language:en
Short-container-title:CCHTS

Author:

Li Xiuqin¹,Chen Shaopeng²,Shao Weihua¹,Wang Suxing¹,Yao Lixia¹

Affiliation:

1. Department of Geriatric Cardiology, Hebei General Hospital, NO. 348 Heping West Road, Shijiazhuang, 050050, China

2. Department of Preventive Health, Hebei General Hospital, NO. 348 Heping West Road, Shijiazhuang, 050050, China

Abstract

Aim: To study the effect of Rhodiola rosea injection on cardiac function and the reninangiotensin- aldosterone system (RASS) in rats with chronic heart failure Background: Rhodiola rosea injection, a traditional Chinese medication for relieving blood stasis and improving blood circulation, is an excellent therapeutic for treating coronary heart disease-angina pectoris. Rhodiola rosea injection's major component, salidroside, protects the cardiovascular system. But there isn't much first-hand evidence about how injectable Rhodiola rosea affects heart failure Objectives: In this study, a rat model of heart failure was established, and the effect of Rhodiola rosea injection on myocardial cell morphology, cardiac function, and ventricular remodelling in rats with heart failure was investigated. Methods: 66 SD male rats were selected; 10 were randomly selected as a blank control group, and 56 were treated intraperitoneally with doxorubicin (4 g/g). After 6 weeks, all animals had LVEF 60%. Established a heart failure model. Each group had 14 rats: model control, low-dose, mediumdose, and high-dose Rhodiola rosea injection. The 2mL/kg of Rhodiola rosea injection was injected into the tail vein once a day for 2 weeks. Both the blank and control groups received normal daily saline. After 2 weeks, the echocardiographic index, RASS-related index, and serum BNP level were assessed in all rats, and myocardial tissue morphology was observed. MiRNA423-5p, miRNA499- 5p, and miRNA210-3p were extracted from peripheral blood. Rhodiola rosea injection on its expression was compared to healthy control rats. Results: 6 mL/kg Rhodiola rosea injection lowered LVEDV and LVESV while increasing LVEF and LVFS. Injections of 6 mL/kg Rhodiola rosea reduce plasma levels of miR-210-3p, miR-423- 5p, miRNA-499, and BNP in heart failure model rats. The 6 mL/kg Rhodiola rosea injection can restore the RASS indexes of heart failure rats to the level of the normal group. Conclusion: The present study offers preliminary evidence supporting the use of Rhodiola rosea injection in the treatment of heart failure and offers a solid foundation for clinical off-label medication use.

Publisher

Bentham Science Publishers Ltd.

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,General Medicine

Reference41 articles.

1. Bard M.; Woods R.A.; Bartón D.H.R.; Corrie J.E.T.; Widdowson D.A.; Sterol mutants of Saccharomyces cerevisiae: Chromatographic analyses. Lipids 1977,12(8),645-654

2. Zhang W.; Brombosz S.M.; Mendoza J.L.; Moore J.S.; A high-yield, one-step synthesis of o-phenylene ethynylene cyclic trimer via precipitation-driven alkyne metathesis. J Org Chem 2005,70(24),10198-10201

3. Guan H.; Dai G.H.; Gao W.L.; Zhao X.; Cai Z.H.; Zhang J.Z.; Yao J.X.; A 5-year survival prediction model for chronic heart failure patients induced by coronary heart disease with traditional chinese medicine intervention. Evid Based Complement Alternat Med 2021,2021,1-10

4. Ambrosy A.P.; Fonarow G.C.; Butler J.; Chioncel O.; Greene S.J.; Vaduganathan M.; Nodari S.; Lam C.S.P.; Sato N.; Shah A.N.; Gheorghiade M.; The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014,63(12),1123-1133

5. McDonagh T.A.; Metra M.; Adamo M.; Gardner R.S.; Baumbach A.; Böhm M.; Burri H.; Butler J.; Čelutkienė J.; Chioncel O.; Cleland J.G.F.; Coats A.J.S.; Crespo-Leiro M.G.; Farmakis D.; Gilard M.; Heymans S.; Hoes A.W.; Jaarsma T.; Jankowska E.A.; Lainscak M.; Lam C.S.P.; Lyon A.R.; McMurray J.J.V.; Mebazaa A.; Mindham R.; Muneretto C.; Francesco Piepoli M.; Price S.; Rosano G.M.C.; Ruschitzka F.; Kathrine Skibelund A.; de Boer R.A.; Christian Schulze P.; Abdelhamid M.; Aboyans V.; Adamopoulos S.; Anker S.D.; Arbelo E.; Asteggiano R.; Bauersachs J.; Bayes-Genis A.; Borger M.A.; Budts W.; Cikes M.; Damman K.; Delgado V.; Dendale P.; Dilaveris P.; Drexel H.; Ezekowitz J.; Falk V.; Fauchier L.; Filippatos G.; Fraser A.; Frey N.; Gale C.P.; Gustafsson F.; Harris J.; Iung B.; Janssens S.; Jessup M.; Konradi A.; Kotecha D.; Lambrinou E.; Lancellotti P.; Landmesser U.; Leclercq C.; Lewis B.S.; Leyva F.; Linhart A.; Løchen M-L.; Lund L.H.; Mancini D.; Masip J.; Milicic D.; Mueller C.; Nef H.; Nielsen J-C.; Neubeck L.; Noutsias M.; Petersen S.E.; Sonia Petronio A.; Ponikowski P.; Prescott E.; Rakisheva A.; Richter D.J.; Schlyakhto E.; Seferovic P.; Senni M.; Sitges M.; Sousa-Uva M.; Tocchetti C.G.; Touyz R.M.; Tschoepe C.; Waltenberger J.; Adamo M.; Baumbach A.; Böhm M.; Burri H.; Čelutkienė J.; Chioncel O.; Cleland J.G.F.; Coats A.J.S.; Crespo-Leiro M.G.; Farmakis D.; Gardner R.S.; Gilard M.; Heymans S.; Hoes A.W.; Jaarsma T.; Jankowska E.A.; Lainscak M.; Lam C.S.P.; Lyon A.R.; McMurray J.J.V.; Mebazaa A.; Mindham R.; Muneretto C.; Piepoli M.F.; Price S.; Rosano G.M.C.; Ruschitzka F.; Skibelund A.K.; 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021,42(36),3599-3726

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative analysis of active components in Rhodiola species based on disease module-guided network pharmacology;Arabian Journal of Chemistry;2024-02

2. Mechanism of Nardostachyos Radix et Rhizoma–Salidroside in the treatment of premature ventricular beats based on network pharmacology and molecular docking;Scientific Reports;2023-11-25

3. Mechanism of Nardostachyos Radix et Rhizoma (NRER)-Salidroside in the Treatment of Premature Ventricular Beats Based on Network Pharmacology and Molecular Docking;2023-09-19

4. Phenolic Compounds of Rhodiola rosea L. as the Potential Alternative Therapy in the Treatment of Chronic Diseases;International Journal of Molecular Sciences;2023-07-31

5. Individual Differences in Growth and in Accumulation of Secondary Metabolites in Rhodiola rosea Cultivated in Western Siberia;International Journal of Molecular Sciences;2023-07-08